Icon

LIPTRUZET (nda200153)- (EQ 10MG BASE;10MG,EQ 20MG BASE;10MG,EQ 40MG BASE;10MG,EQ 80MG BASE;10MG)

ATORVASTATIN CALCIUM; EZETIMIBE ORGANON
EQ 10MG BASE;10MG,EQ 20MG BASE;10MG,EQ 40MG BASE;10MG,EQ 80MG BASE;10MG
No Yes
2017-Apr-25 Expired
None None
None No
LIPTRUZET, which contains a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor (statin), is indicated as adjunctive therapy to diet to: • reduce elevated total-C, LDL-C, Apo B, TG, and non-HDL-C, and to increase HDL-C in patients with primary (heterozygous familial and non-familial) hyperlipidemia or mixed hyperlipidemia. • reduce elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia (HoFH), as an adjunct to other lipid-lowering treatments.
1 0 1
Total Other Developers None
Drugs with Suitability No
EQ 10MG BASE;10MG ** ** - - -
EQ 20MG BASE;10MG ** ** - - -
EQ 40MG BASE;10MG ** ** - - -
EQ 80MG BASE;10MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******* ***************, *** *********** ** ************ ***** ***** ****, **********, *** ****** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.